This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Basel, CH (2022)
- Riehen, CH (2024)
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Journey of Tobias Schmelzle
Introduction
Tobias Schmelzle, an accomplished inventor based in Basel, Switzerland, is recognized for his significant contributions to the field of pharmaceutical developments. With a total of two patents to his name, Schmelzle has been instrumental in advancing therapies aimed at treating cancer.
Latest Patents
Tobias Schmelzle's latest patents include innovations in the form of biaryl derivatives that function as YAP/TAZ-TEAD protein-protein interaction inhibitors. This invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, highlighting significant advancements in cancer treatment. Additionally, he has developed compositions and methods geared toward novel personalized therapies which involve kits, transmittable forms of information, and methodologies tailored for treating patients with cancer. These breakthroughs address various targets and include methods for screening candidate inhibitors alongside associated treatment methods.
Career Highlights
Currently, Tobias Schmelzle is affiliated with Novartis AG, where he applies his expertise to foster innovative solutions within the pharmaceutical sector. His work emphasizes the intersection of cutting-edge research and practical application in medicine, showcasing his commitment to enhancing patient outcomes through innovative drug development.
Collaborations
At Novartis AG, Tobias works alongside notable colleagues such as Eric Billy and Antoine De Weck. This collaborative environment fosters the exchange of ideas and techniques, ultimately contributing to the advancement of their shared goals in the field of cancer research and treatment.
Conclusion
Tobias Schmelzle's journey as an inventor is marked by remarkable contributions that have the potential to revolutionize cancer treatment. His dedication to innovation, combined with collaborative efforts at Novartis AG, lays a promising foundation for future advancements in personalized therapies, underscoring the invaluable role of inventors in the realm of medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile